These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3411179)

  • 1. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
    Nader S; Berkowitz AS; Ochs D; Held B; Winkel CA
    J In Vitro Fert Embryo Transf; 1988 Apr; 5(2):81-4. PubMed ID: 3411179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.
    Buvat J; Marcolin G; Herbaut JC; Dehaene JL; Verbecq P; Fourlinnie JC
    Fertil Steril; 1988 Mar; 49(3):458-61. PubMed ID: 3277865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteal rescue in in vitro fertilization-embryo transfer.
    Hutchinson-Williams KA; DeCherney AH; Lavy G; Diamond MP; Naftolin F; Lunenfeld B
    Fertil Steril; 1990 Mar; 53(3):495-501. PubMed ID: 2307247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens.
    Wong YF; Loong EP; Mao KR; Tam PP; Panesar NS; Neale E; Chang AM
    Reprod Fertil Dev; 1990; 2(4):351-8. PubMed ID: 2217893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
    Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
    VandeVoort CA; Hess DL; Stouffer RL
    Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
    J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
    Huang KE; Muechler EK; Schwarz KR; Goggin M; Graham MC
    Fertil Steril; 1986 Nov; 46(5):903-6. PubMed ID: 3096786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
    Buvat J; Marcolin G; Guittard C; Herbaut JC; Louvet AL; Dehaene JL
    Fertil Steril; 1990 Mar; 53(3):490-4. PubMed ID: 2407565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
    Hara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.
    Artini PG; Volpe A; Angioni S; Galassi MC; Battaglia C; Genazzani AR
    J Endocrinol Invest; 1995 Jan; 18(1):51-6. PubMed ID: 7759785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.
    Mahadevan MM; Leader A; Taylor PJ
    J In Vitro Fert Embryo Transf; 1985 Dec; 2(4):190-4. PubMed ID: 4093702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.
    Liu HC; Pyrgiotis E; Davis O; Rosenwaks Z
    Early Pregnancy; 1995 Dec; 1(4):281-7. PubMed ID: 9363260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction.
    Vicdan K; Zeki Isik A
    Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):98-101. PubMed ID: 11311769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.